Health Care Industry Faces Uncertainty Amid Absence of Clear Antitrust Guidelines

Over a year since the U.S. Department of Justice (DOJ) and Federal Trade Commission (FTC) withdrew longstanding antitrust guidelines, the health care industry remains uncertain about what actions might provoke regulatory scrutiny. This uncertainty has heightened due to the lack of clear direction. Antitrust attorney Michelle Mantine noted, “Without those guidelines, you’re kind of left scratching your head in terms of what would be acceptable to the agencies.” For further insights on the ongoing challenges faced by the industry, visit the original article.